Infection with hepatitis C virus (HCV) can cause several significant h
ealth problems. Sensitive and specific assays for antibodies to HCV ar
e available to identify and confirm individuals infected with HCV. Eva
luation of the clinical impact of HCV infection in a patient includes
measuring liver biochemistries and possibly liver biopsy. Molecular as
says such as HCV genotype identification and qualitative/quantitative
HCV RNA analyses may be valuable in considerations of prognosis and th
erapy. Further refinement of antibody screening and confirmatory assay
s and standardization of molecular testing are necessary to optimize t
esting and thus fully characterize the diagnosis of HCV infection.